EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

17β-Estradiol Modulates Cancer Cell–Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer

Rosa Vona iD, Camilla Cittadini, Barbara Ascione, Lucrezia Gambardella iD, Katia Fecchi, Lucia Bertuccini iD, Annalisa Tocci iD, Lorenzo D'Ambrosio iD, Maria Cristina Gagliardi, Federica Felicetti iD, Elena Ortona, Paola Nisticò und 2 weitere

International Journal of Molecular Sciences · 21.08.2026 · 27 (16) · 7490

DOI: 10.3390/ijms27167490 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.08.2026. Verfasst von Rosa Vona und 13 weiteren Autor:innen. Beteiligte Einrichtung: Center for Gender-Specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], Viale Regina Elena, 299-00161 Rome, Italy. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Estradiol, Autophagy, Lung Neoplasms. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality. Smoking is the primary etiological factor, but growing evidence suggests the involvement of estrogen in its development and progression, although its role remains unclear. This study explores: (i) the effects induced by estrogen, namely, 17β-estradiol (E2), alone or in combination with a mixture of inflammatory cytokines (Mix), in two human NSCLC cell lines, A549 and Calu1, and (ii) whether and how tumor cells can modulate the activation of normal lung fibroblasts. We found that E2 significantly enhances migration, invasion, and epithelial–mesenchymal transition in NSCLC cells, as well as their resistance to cisplatin, particularly in combination with Mix. Pharmacological inhibition of ERβ reversed the E2-induced effects, implicating ERβ in E2-mediated signaling. Furthermore, E2 increased autophagic flux and induced a shift toward secretory autophagy and the release of extracellular vesicles, which activated normal lung fibroblasts, as demonstrated by the increased expression of α-SMA, FAP, PDGFR-β, and PDPN. The clinical relevance of these data was supported by computational analyses revealing an elevated expression of the Mix gene signature, including TGF-β, IL-6, IL-8, CCXL-16, and ERβ, which was associated with shorter overall survival in NSCLC patients. This molecular profile was linked to the elevated expression of secretory autophagy genes and cancer-associated fibroblast markers. Validation in three large clinical cohorts (TCGA-LUNG, OAK and POPLAR) strengthens the clinical relevance of this E2-related pro-tumor axis while suggesting a promising therapeutic avenue for NSCLC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungEstradiolAutophagyLung NeoplasmsFibroblastsCell CommunicationCancer-Associated FibroblastsHumansCell MovementEpithelial-Mesenchymal TransitionPrognosisCell Line, TumorSignal TransductionEstrogen Receptor betaCytokinesGene Expression Regulation, NeoplasticA549 Cells

Stichwörter der Autor:innen

estrogen receptor βestrogenslung cancertumor microenvironmenttumor progression

Substanzen

EstradiolEstrogen Receptor betaCytokines

Autor:innen und Institutionen

  • Center for Gender-Specific Medicine, Istituto Superiore di Sanità [Italian National Institute of Health], Viale Regina Elena, 299-00161 Rome, Italy.
  • Department of Infectious Diseases, Istituto Superiore di Sanità, Viale Regina Elena, 299-00161 Rome, Italy.
  • Core Facilities, Italian National Institute of Health, Viale Regina Elena, 299-00161 Rome, Italy.
  • Tumor Immunology and Immunotherapy Unit, IRCCS Regina Elena National Cancer Institute, Via Elio Chianesi, 53-00144 Rome, Italy.

ORCID-Profile: Rosa Vona, Lucrezia Gambardella, Lucia Bertuccini, Annalisa Tocci, Lorenzo D'Ambrosio, Federica Felicetti, Anna Maria Mileo, Paola Matarrese

Förderung

  • European Union

Zitieren

APA

Vona, R., Cittadini, C., Ascione, B., Gambardella, L., Fecchi, K., Bertuccini, L., Tocci, A., D'Ambrosio, L., Gagliardi, M. C., Felicetti, F., Ortona, E., Nisticò, P., Mileo, A. M., & Matarrese, P. (2026). 17β-Estradiol Modulates Cancer Cell–Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 27(16), 7490. https://doi.org/10.3390/ijms27167490

Vancouver

Vona R, Cittadini C, Ascione B, Gambardella L, Fecchi K, Bertuccini L, et al. 17β-Estradiol Modulates Cancer Cell–Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2026;27(16):7490. doi:10.3390/ijms27167490

BibTeX
@article{Vona2026,
  author = {Vona, Rosa and Cittadini, Camilla and Ascione, Barbara and Gambardella, Lucrezia and Fecchi, Katia and Bertuccini, Lucia and Tocci, Annalisa and D'Ambrosio, Lorenzo and Gagliardi, Maria Cristina and Felicetti, Federica and Ortona, Elena and Nisticò, Paola and Mileo, Anna Maria and Matarrese, Paola},
  title = {17β-Estradiol Modulates Cancer Cell–Fibroblast Communication via Autophagy-Mediated Extracellular Vesicle Secretion and Promotes Poor Prognosis in Non-Small Cell Lung Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {16},
  pages = {7490},
  doi = {10.3390/ijms27167490}
}
Kostenlos starten →